Table 4 Twelve-month change in gene expression (unsupervised) according to vitamin D repletion status (25(OH)D</≥32 ng/mL) among women randomized to 2000 IU vitamin D
Gene | All | <32 ng/ml at 12 mo | ≥32 ng/ml at 12 mo | p* |
|---|---|---|---|---|
AB | N = 28 | N = 11 | N = 17 | |
VDR | −9.8% | −16.3% | −5.9% | 0.611 |
CYP19A1 | −17.0% | −7.6% | −24.1% | 0.956 |
PPARg | 11.6% | 10.0% | 12.8% | 0.239 |
Adipoq | 5.7% | 15.1% | −0.6% | 0.068 |
MCP-1 | 16.1% | 12.3% | 19.2% | 0.084 |
RPFNA | N = 29 | N = 12 | N = 17 | |
VDR | −9.8% | −6.8% | −11.2% | 0.435 |
CYP19A1 | 33.0% | 104.1% | −5.3% | 0.422 |
PPARg | 35.1% | 45.8% | 29.0% | 0.351 |
Adipoq | 16.4% | 15.4% | 17.0% | 0.367 |
MCP-1 | 21.0% | 61.2% | −1.6% | 0.015 |